|

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2026-02-04
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07140757

Summary

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Eligibility Criteria

1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
2. Participant is over 18 years and is either not a surgical candidate or has declined surgery.
3. Capable and willing to provide written informed consent
4. Participant has one of the following diagnoses:

   * Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
   * Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
   * Papillary thyroid carcinoma (PTC) without metastasis
   * Locally recurrent thyroid cancer (\< 2 cm).

Exclusion Criteria

1. Participants meeting any of the following criteria will be excluded:
2. Participants considered unsuitable for RFA by the treating physician

Conditions4

CancerLow RiskPapillary Thyroid CancerRadiofrequency Ablation

Locations1 site

MD Anderson Cancer Center
Houston, Texas, 77030
Victoria E Banuchi, MD346-217-8668VEBanuchi@mdanderson.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.